Clove Oil-based Nanoemulsion Co-loaded With Saquinavir, Ritonavir and Acyclovir for Enhanced Oral Pharmacokinetics and Brain Exposure in Herpes Simplex Encephalitis and NeuroAIDS
Aug 2026· Journal of cluster science· Vol 37· 0 citations· 76 references
TL;DR
It is suggested that the triple drug-loaded nanoemulsion represents a promising oral delivery platform improves the pharmacokinetic performance and brain exposure of antiviral agents, with potential application in the management of HIV-1 and HSV co-infections.
These findings provide pharmacokinetic proof-of-concept supporting further investigation of this intranasal formulation for CNS delivery of DMF, and show high biocompatibility and reciprocal enhancement of stability.
E. S. Cama, Giada Botti, S. Perteghella et al.· Pharmaceutics· 0 citations
The developed SEDDS formulation increased solubility, dissolution, plasma exposure, and therapeutic effectiveness of IIIM-019, representing a promising carrier for oral administration of investigated anti-tubercular lead.
G. Paudwal, Rigzin Dolkar, Anjali Negi et al.· AAPS PharmSciTech· 0 citations
The optimized nanoemulsion-based in situ gel demonstrated sustained drug release, enhanced nasal permeation, acceptable safety, and improved antidepressant efficacy and Pharmacodynamic evaluation showed significantly greater reduction in depressive-like behaviours than oral escitalopram solution.
Vahid Vikram Minglani, Meenakshi Patel, Tarun Kumar Upadhyay· DARU Journal of Pharmaceutic...· 1 citation
Tuberculosis (TB) remains a major global health threat, compounded by prolonged treatment regimens, drug toxicity, and the emergence of multidrug-resistant Mycobacterium tuberculosis strains. In this study, we present a novel therapeutic strategy integrating co-crystallization and nanocarrier engineering to enhance the...
Xiao-Guo Zhang, Ping Liu, Sheng-Wei Ji et al.· European journal of pharmace...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.